Published in World J Gastroenterol on February 28, 2016
Serum liver enzymes serve as prognostic factors in patients with intrahepatic cholangiocarcinoma. Onco Targets Ther (2017) 0.75
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Bilirubin is an antioxidant of possible physiological importance. Science (1987) 11.26
UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity. Pharmacogenomics J (2002) 2.77
Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol (2001) 2.54
The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision. Ann Surg (2009) 2.32
Serum bilirubin and colorectal cancer risk: a population-based cohort study. Aliment Pharmacol Ther (2006) 2.06
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients: a meta-analysis. Scand J Gastroenterol (2012) 1.71
Relationship of baseline serum bilirubin to efficacy and toxicity of single-agent irinotecan in patients with metastatic colorectal cancer. J Clin Oncol (2004) 1.62
Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Control (2001) 1.60
Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer. Hepatology (2004) 1.36
Lymph node retrieval in rectal cancer is dependent on many factors--the role of the tumor, the patient, the surgeon, the radiotherapist, and the pathologist. Am J Surg Pathol (2009) 1.29
The role of vascular cell adhesion molecule-1 in tumor immune evasion. Cancer Res (2007) 1.18
Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reports. Ann Oncol (1997) 1.18
Unconjugated bilirubin inhibits VCAM-1-mediated transendothelial leukocyte migration. J Immunol (2005) 1.11
Risk factors of lateral pelvic lymph node metastasis in advanced rectal cancer. Int J Colorectal Dis (2009) 0.99
Unconjugated bilirubin induces apoptosis in colon cancer cells by triggering mitochondrial depolarization. Int J Cancer (2004) 0.99
Predicting lymph node metastases in early rectal cancer. Eur J Cancer (2012) 0.96
Risk factors for lymph node metastasis in pT1 and pT2 rectal cancer: a single-institute experience in 943 patients and literature review. Ann Surg Oncol (2012) 0.94
Diabetes mellitus: a "true" independent risk factor for hepatocellular carcinoma? Hepatobiliary Pancreat Dis Int (2009) 0.92
Diabetes mellitus and hepatocellular carcinoma: comparison of Chinese patients with and without HBV-related cirrhosis. World J Gastroenterol (2010) 0.89
Potential role of diabetes mellitus in the progression of cirrhosis to hepatocellular carcinoma: a cross-sectional case-control study from Chinese patients with HBV infection. Hepatobiliary Pancreat Dis Int (2013) 0.87
Prognostic value of lateral lymph node metastasis for advanced low rectal cancer. World J Gastroenterol (2007) 0.87
Serum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancer. J Natl Cancer Inst (1994) 0.84
Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer. Int J Cancer (2012) 0.84
Prognostic significance of apical lymph node metastasis in patients with node-positive rectal cancer. Colorectal Dis (2013) 0.82
Increased international normalized ratio level in hepatocellular carcinoma patients with diabetes mellitus. World J Gastroenterol (2013) 0.79
Depth of tumor invasion independently predicts lymph node metastasis in T2 rectal cancer. J Gastrointest Surg (2010) 0.78
Pre-operative predictive factors for intra-operative pathological lymph node metastasis in rectal cancers. Asian Pac J Cancer Prev (2013) 0.77
Drug allergy and the risk of lymph node metastasis in rectal cancer. PLoS One (2014) 0.77